FDA Lists Discontinued Hydrocortisone Acetate Injection (ANDA085214)

The U.S. Food and Drug Administration (FDA) has a record for an injectable product containing Hydrocortisone Acetate. The product, marketed by Watson Labs, is identified as a 50 mg/mL injectable solution. It is listed under application number ANDA085214. The FDA entry indicates the product is discontinued and was not designated as a reference drug or reference standard. No further marketing status or approval details are provided beyond the discontinuation notice.